Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SurModics Inc (NASDAQ:SRDX)

Delayed Data
As of Feb 11
 -0.26 / -1.39%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

SurModics, Inc. is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company offers surface modification coating technologies and components for in vitro diagnostic test kits and microarrays. It operates through two segments: The Medical Device unit and The In Vitro Diagnostics unit. The Medical Device unit, which is comprised of surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, and neuro-vascular, and urology, among others. The In Vitro Diagnostics unit, which consists of component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings. SurModics was founded in June 1979 and is headquartered in Eden Prairie, MN.

Contact Information

SurModics, Inc.
9924 West 74th Street
Eden Prairie Minnesota 55344-3523
P:(952) 500-7000
Investor Relations:



Other institutional45.40%
Mutual fund holders45.38%
Individual stakeholders42.73%

Top Executives

Gary R. MaharajPresident, Chief Executive Officer & Director
Andrew D. C. LaFrenceCFO, VP & Head-Investor Relations
Charles W. OlsonSenior Vice President & GM-Medical Device
Joseph J. StichVice President & GM-In Vitro Diagnostics
Timothy J. ArensVice President-Corporate Development & Strategy